Results did not improve substantially with the addition of carbonic anhydrase (CA) IX and smooth muscle actin (SMA) immunostaining to highlight tumor cells and pericytes, respectively, for exclusion during EC classification. The gene discussed is SMN1; the disease is neoplasm.